KESSA THORPE: Open Payments
NPI 1346267119 · BUCKHANNON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 42 payments from 16 companies in 2025. Trend: 2023 $768 · 2024 $772 · 2025 $754
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $233 |
| ABBVIE INC. | 6 | $105 |
| Novo Nordisk Inc | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Alkermes, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Dexcom, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
| Braeburn Inc. | 1 | $19 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, JARDIANCE, VIVITROL, Rybelsus, VOQUEZNA, Dexcom G6 Transmitter.
Industry payments across WV — which companies pay providers there.
